Our Bureau

Mumbai, March 3

Lupin Ltd has entered into an agreement with Chester Valley Pharmaceuticals in the US to promote Atopiclair non-steroidal cream to paediatricians.

The agreement was formalised through its wholly owned subsidiary, Lupin Pharmaceuticals Inc, a company communiqué said. Atopiclair non-steroidal cream is used in skin-related indications, to relieve symptoms of atopic dermatitis and allergic contact dermatitis.

As per the agreement, Lupin's paediatric sales force will promote Atopiclair cream. Lupin had created a dedicated paediatric sales force to promote its third generation cephalosporin, Suprax, also in the US.

(This article was published in the Business Line print edition dated March 4, 2006)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.